Letter of Intent
(LOI) for CRADA
Prior to final approval of the CRADA, a Letter of Intent
(LOI) may be signed allowing the research to proceed pending
final negotiation and review. If
negotiations are lengthy and the scientists wish to proceed
before the CRADA is executed the collaborator may request
the execution of a Letter of Intent.
Materials-Cooperative
Research and Development Agreement (Materials CRADA)
This is a simpler form of
CRADA. It is limited in time to one year and does not allow
for funds to be provided for support of research personnel,
but does provide for the transfer of intellectual property
rights to the collaborator. May
be necessary in instance where, a company is providing an
otherwise un-available material and requests an option to
exclusively license intellectual property arising from the
research.
Material Transfers
(make documents in this sectionactive)
Used for the exchange of materials
with outside organizations for research purposes. NIH Staff
may use either the Simple Letter of Agreement (SLA) [PDF
| Word] or the NIH Material Transfer Agreement (MTA) [PDF
| Word]. MTA for software (Word). Frequently asked questions
about the Simple Letter of Agreement.
Uniform Biological
Material Transfer Agreement (UBMTA)
Implementing
Letter Procedures (for use with non-profit organizations)
This agreement is only used with non-profit organizations
that, along with NIH, have signed a Master Agreement. For
a complete listing of UMBTA signatories, check the Autm
(Association of University Technology Mangers) Website (http:www.autm.net/ubmta/signatories.html)
Letter of Collection
Used for collecting materials
from a foreign country for screening, evaluation and testing.
Also see MOU - used when the foreign country provides extracts
and compounds directly to the NCI.
Employee Invention
Report (EIR)
Used by NIH staff for reporting
and evaluating inventions.
Confidential
Disclosure Agreement (CDA)
Used for the exchange of confidential
information. There are 3 different versions of the CDA.
Select from the following: